| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
ENDRA Life Sciences Inc. specializes in advancing the capabilities of clinical diagnostic ultrasound. The company's primary development is thermo-acoustic enhanced ultrasound technology, which operates by emitting sound waves that echo off internal body components such as tissues, organs, and blood. This innovation is utilized in managing nonalcoholic fatty liver disease, meticulously monitoring temperature during thermoablative surgical procedures, detailed vascular imaging, and assessing tissue perfusion. Furthermore, ENDRA offers other …
Over the last 12 months, insiders at ENDRA Life Sciences Inc. have bought $0 and sold $0 worth of ENDRA Life Sciences Inc. stock.
On average, over the past 5 years, insiders at ENDRA Life Sciences Inc. have bought $57,833 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 0 shares for transaction amount of $0 was made by UBS Group AG (Market maker/broker‑dealer) on 2024‑08‑27.
| 2024-08-27 | UBS Group AG | Market maker/broker-dealer | 0 – | $0 | $0 | -71.52% | ||
| 2023-05-18 | Thornton Michael Milos | Chief Technology Officer | 15,000 0.8073% | $1.65 | $24,750 | -21.68% | ||
| 2023-05-02 | DIGIANDOMENICO ANTHONY | director | 83,333 3.2618% | $1.20 | $100,000 | -32.94% | ||
| 2022-12-09 | Thornton Michael Milos | Chief Technology Officer | 1,500 0.1664% | $3.40 | $5,100 | -56.85% | ||
| 2022-11-23 | Tokman Alexander Y | director | 10,000 0.0555% | $0.17 | $1,700 | -54.13% | ||
| 2022-08-22 | Thornton Michael Milos | Chief Technology Officer | 20,000 0.1761% | $0.27 | $5,400 | -32.08% | ||
| 2022-08-22 | Tokman Alexander Y | 20,000 0.1696% | $0.26 | $5,200 | -32.08% | |||
| 2022-05-26 | Thornton Michael Milos | Chief Technology Officer | 25,000 0.1712% | $0.21 | $5,250 | -6.22% | ||
| 2022-05-18 | Thornton Michael Milos | Chief Technology Officer | 25,000 0.1794% | $0.22 | $5,500 | -1.74% | ||
| 2022-05-17 | Michelon Francois Roger | Chief Executive Officer | 5,100 0.0316% | $0.19 | $969 | +18.62% | ||
| 2022-05-16 | Tokman Alexander Y | 100,000 0.6403% | $0.20 | $19,630 | +15.61% | |||
| 2021-08-26 | Sale | Basenese Lou | director | 5,000 0.3017% | $1.85 | $9,250 | -78.92% | |
| 2021-08-25 | Sale | Basenese Lou | director | 45,000 2.6861% | $1.83 | $82,350 | -76.76% | |
| 2021-04-07 | Sale | Thornton Michael Milos | Chief Technology Officer | 15,000 1.2379% | $2.53 | $37,950 | -35.26% | |
| 2021-03-29 | Sale | Thornton Michael Milos | Chief Technology Officer | 18,750 1.4495% | $2.37 | $44,438 | -28.33% | |
| 2021-01-13 | Sale | Maloberti Renaud Bertrand | Chief Commercial Officer | 13,696 0.4914% | $1.10 | $15,066 | +87.50% | |
| 2021-01-12 | Sale | Maloberti Renaud Bertrand | Chief Commercial Officer | 6,304 0.2159% | $1.05 | $6,619 | +85.71% | |
| 2021-01-08 | Sale | Tokman Alexander Y | director | 10,000 0.2936% | $0.90 | $9,000 | +111.96% | |
| 2021-01-08 | Sale | Maloberti Renaud Bertrand | Chief Commercial Officer | 8,731 0.2677% | $0.94 | $8,207 | +111.96% | |
| 2021-01-06 | Sale | Wells David R. | Chief Financial Officer | 34,900 1.0245% | $0.90 | $31,410 | +131.95% |
| Increased Positions | 5 | +62.5% | 71,788 | +548.59% |
| Decreased Positions | 4 | -50% | 13,049 | -99.72% |
| New Positions | 4 | New | 71,784 | New |
| Sold Out Positions | 2 | Sold Out | 12,939 | Sold Out |
| Total Postitions | 9 | +12.5% | 71,825 | +448.87% |
| Drw Securities, Llc | $55.00 | 1.27% | 12,714 | +12,714 | New | 2025-09-30 |
| Tower Research Capital Llc (Trc) | $1.00 | 0.02% | 225 | +225 | New | 2025-09-30 |
| Ubs Group Ag | $0 | 0.01% | 106 | -4,589 | -97.74% | 2025-09-30 |
| Northwestern Mutual Wealth Management Co | $0 | <0.01% | 35 | 0 | 0% | 2025-09-30 |
| Bank Of America Corp /De/ | $0 | <0.01% | 6 | 0 | 0% | 2025-09-30 |